BRAF^V600E Inhibitor Radiosensitizes Thyroid Cancer-Letter

Clin Cancer Res. 2019 Nov 1;25(21):6556. doi: 10.1158/1078-0432.CCR-19-2205.

Authors

Eva-Leonne Göttgens¹, Katrin Rabold^{2

3}, Paul N Span²

Affiliations

¹ Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Eva-Leonne.Gottgens@radboudumc.nl.
² Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
³ Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

PMID: 31676589
DOI: 10.1158/1078-0432.CCR-19-2205

No abstract available

Publication types

Letter
Comment

MeSH terms

DNA
Humans
Oncogenes
Proto-Oncogene Proteins B-raf / genetics*
Thyroid Neoplasms / genetics*

Substances

DNA
BRAF protein, human
Proto-Oncogene Proteins B-raf